Montpellier, January 18th 2024 – French medical robotics company Quantum Surgical expands its Scientifc Advisory Board (SAB) with the appointments of Pr. Laurent Milot (Hospices Civils de Lyon) and Dr. Govindarajan Naranayan (Miami). The physicians will bring their expertise to develop the adoption of Epione®, Quantum Surgical’s tumor-treating robotic platform and provide guidance for and participate in the dissemination of clinical outcomes.
French medical robotics Quantum Surgical announced today the expansion of its Scientific Advisory Board (SAB) with the appointment of Pr. Laurent Milot, Deputy Chief Vascular & Interventional Radiology at the Hospices Civils de Lyon and Dr. Govindarajan Naranayan, Chief of interventional oncology in Miami.
“We are honored and delighted to expand our SAB with the appointment of Pr. Laurent Milot and Dr. Govindarajan Naranayan, seasoned users of Epione®. Their experience and advice, combined with those of the other SAB members’, will help and support the adoption of Quantum Surgical’s tumor-treating robot in the European and American markets” says Bertin Nahum, CEO and co-founder of Quantum Surgical.
“We are thrilled to have Pr. Milot and Dr. Naranayan, two of our top users, joining the SAB. Their experience with Epione® will be extremely valuable to advise on Quantum Surgical’s clinical strategy and help develop its adoption” says Laetitia Messner, Chief Clinical Officer at Quantum Surgical.
The Quantum Surgical SAB is a multi-disciplinary board composed of international experts in the field of image-guided interventional oncology:
- Professor Steven D. Colquhoun (US), Professor of Surgical Oncology, Liver, Pancreas & Biliary Surgery, Medical College of Georgia (GA)
- Professor Thierry De Baere (FR), Interventional radiologist at Gustave Roussy Cancer Center (Villejuif).
- Professor Nishita Kothary (US), Interventional Radiologist at Stanford University Medical Center (Stanford, CA).
- Professor David C. Madoff (US), Interventional Radiologist at Yale New Haven Hospital (New Haven, CT).
- Professor Laurent Milot (FR), Deputy Chief Vascular & Interventional Radiology at the Hospices Civils de Lyon.
- Dr. Govindarajan Naranayan (USA), Chief of interventional oncology in Miami.
Professor Luigi Solbiati (IT), Interventional Radiologist, pioneer of percutaneous liver ablation techniques, Professor of Radiology at Humanitas University (Rozzano – Milan), is honorary member of this Scientific Advisory Board.
Epione® is a robot-assisted technology that allows physicians to perform safe and effective percutaneous tumor ablations, a minimally invasive treatment in which one or several needles are inserted through the skin to the tumor to destroy it.
Epione® is CE marked in Europe for abdomen and lung tumors, and FDA cleared for abdominal tumors. Epione® is available at the Gustave Roussy Cancer Center in Villejuif, as well as at the Hospices Civils de Lyon and in Miami. Hundreds of patients have already been treated worldwide.
About Quantum Surgical
Quantum Surgical is a French medical robotics company founded in Montpellier. Its Epione® robotic percutaneous ablation platform is dedicated to the curative and early treatment of cancers. Quantum Surgical thus offers a new approach to cancer treatment by standardizing access to care. More patients can benefit from innovative, better targeted and less invasive treatments. Hundreds of patients have already been treated worldwide.
Co-founded in 2017 and with a team of 110+ employees, Quantum Surgical is based in Montpellier, with offices in Miami, Florida. Quantum Surgical received the Prix Galien USA in 2022, the equivalent of the Nobel Prize for biopharmaceutical research and joined in 2023 the governmental French Tech 2030 program in 2023 that supports top emerging actors in disruptive innovation.
More information: www.quantumsurgical.com
Press contact Quantum Surgical
Stéphanie Moy
s.moy@quantumsurgical.com
Tel. : +33 (0)6 32 55 85 48
